LTRX vs NVDA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Lantronix exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and strong liquidity ratios, yet it faces significant operational headwinds. While the balance sheet is healthy with low debt (D/E 0.25) and a high current ratio (2.75), the company is struggling with negative revenue growth (-4.5% YoY) and negative profit margins. The stock has experienced a massive 192% price surge over the last year, which appears disconnected from current fundamental performance, creating a valuation gap. Despite analyst optimism with a target price of $9.12, the lack of top-line growth and bearish insider sentiment warrant a cautious approach.
NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.
Compare Another Pair
Related Comparisons
LTRX vs NVDA: Head-to-Head Comparison
This page compares Lantronix, Inc. (LTRX) and NVIDIA Corporation (NVDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.